Long-term findings of HIVNET 012: the next steps
- 1 September 2003
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 362 (9387) , 842-843
- https://doi.org/10.1016/s0140-6736(03)14345-0
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Child survival in relation to mother's HIV infection and survivalAIDS, 2003
- Cross-Resistance among Nonnucleoside Reverse Transcriptase Inhibitors Limits Recycling Efavirenz after Nevirapine FailureAIDS Research and Human Retroviruses, 2002
- Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trialThe Lancet, 2002
- Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)AIDS, 2001
- HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination TherapyJAMA, 2001
- Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1JAMA, 2001
- Effect of Breastfeeding and Formula Feeding on Transmission of HIV-1JAMA, 2000
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trialThe Lancet, 1999
- Rates and risk factors for mortality during the first two years of life in rural MalawiThe American Journal of Tropical Medicine and Hygiene, 1996